Advances in the field of nanooncology

Nanooncology, the application of nanobiotechnology to the management of cancer, is currently the most important chapter of nanomedicine. Nanobiotechnology has refined and extended the limits of molecular diagnosis of cancer, for example, through the use of gold nanoparticles and quantum dots. Nanobiotechnology has also improved the discovery of cancer biomarkers, one such example being the sensitive detection of multiple protein biomarkers by nanobiosensors. Magnetic nanoparticles can capture circulating tumor cells in the bloodstream followed by rapid photoacoustic detection. Nanoparticles enable targeted drug delivery in cancer that increases efficacy and decreases adverse effects through reducing the dosage of anticancer drugs administered. Nanoparticulate anticancer drugs can cross some of the biological barriers and achieve therapeutic concentrations in tumor and spare the surrounding normal tissues from toxic effects. Nanoparticle constructs facilitate the delivery of various forms of energy for noninvasive thermal destruction of surgically inaccessible malignant tumors. Nanoparticle-based optical imaging of tumors as well as contrast agents to enhance detection of tumors by magnetic resonance imaging can be combined with delivery of therapeutic agents for cancer. Monoclonal antibody nanoparticle complexes are under investigation for diagnosis as well as targeted delivery of cancer therapy. Nanoparticle-based chemotherapeutic agents are already on the market, and several are in clinical trials. Personalization of cancer therapies is based on a better understanding of the disease at the molecular level, which is facilitated by nanobiotechnology. Nanobiotechnology will facilitate the combination of diagnostics with therapeutics, which is an important feature of a personalized medicine approach to cancer.

[1]  L. Trahms,et al.  Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies , 2010, Physics in medicine and biology.

[2]  Vladimir P Torchilin,et al.  Passive and active drug targeting: drug delivery to tumors as an example. , 2010, Handbook of experimental pharmacology.

[3]  Jinwoo Cheon,et al.  Biocompatible heterostructured nanoparticles for multimodal biological detection. , 2006, Journal of the American Chemical Society.

[4]  K. Jain,et al.  Role of Nanobiotechnology in Developing Personalized Medicine for Cancer , 2005, Technology in cancer research & treatment.

[5]  Erkki Ruoslahti,et al.  Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.

[6]  Michael Hawkins,et al.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Bischof,et al.  Nanoparticle enhanced thermal therapies , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[8]  G. Dai,et al.  Image-guided breast tumor therapy using a small interfering RNA nanodrug. , 2010, Cancer research.

[9]  K. Jain,et al.  Nanotechnology-based Drug Delivery for Cancer , 2005, Technology in cancer research & treatment.

[10]  Robia G. Pautler,et al.  Nanoshells with Targeted Simultaneous Enhancement of Magnetic and Optical Imaging and Photothermal Therapeutic Response , 2009 .

[11]  Ernst Wagner,et al.  Programmed drug delivery: nanosystems for tumor targeting , 2007, Expert opinion on biological therapy.

[12]  Indrajit Roy,et al.  Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. , 2007, Nano letters.

[13]  R. Blumenthal,et al.  HER2-Specific Affibody-Conjugated Thermosensitive Liposomes (Affisomes) for Improved Delivery of Anticancer Agents , 2008, Journal of liposome research.

[14]  Y. Shimada,et al.  Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Yi Zhang,et al.  MS-qFRET: a quantum dot-based method for analysis of DNA methylation. , 2009, Genome research.

[16]  Hisataka Kobayashi,et al.  Real-time optical imaging using quantum dot and related nanocrystals. , 2010, Nanomedicine.

[17]  Mauro Ferrari,et al.  Antibiological barrier nanovector technology for cancer applications , 2007, Expert opinion on drug delivery.

[18]  R Hergt,et al.  Use of magnetic nanoparticle heating in the treatment of breast cancer. , 2005, IEE proceedings. Nanobiotechnology.

[19]  Y. Matsumura.  Poly (amino acid) micelle nanocarriers in preclinical and clinical studies. , 2008, Advanced drug delivery reviews.

[20]  Sang Hyun Cho,et al.  Nanoparticle-mediated thermal therapy: Evolving strategies for prostate cancer therapy , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[21]  K. Jain,et al.  Applications of nanobiotechnology in clinical diagnostics. , 2007, Clinical chemistry.

[22]  James R Baker,et al.  Dendrimer-based nanoparticles for cancer therapy. , 2009, Hematology. American Society of Hematology. Education Program.

[23]  D. Kerr,et al.  Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. , 2009, International journal of oncology.

[24]  J. Au,et al.  Formulating Paclitaxel in Nanoparticles Alters Its Disposition , 2005, Pharmaceutical Research.

[25]  Hiroyuki Honda,et al.  Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. , 2004, Cancer letters.

[26]  E. Zubarev,et al.  Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.

[27]  Boris Murmann,et al.  Matrix-insensitive protein assays push the limits of biosensors in medicine , 2009, Nature Medicine.

[28]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[29]  R. Weissleder,et al.  Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. , 2009, Clinical imaging.

[30]  K. Gelmon,et al.  Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors , 2009, Clinical Cancer Research.

[31]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[32]  Jon Cardinal,et al.  Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. , 2008, Surgery.

[33]  M. Ranson,et al.  A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction , 2011, Investigational New Drugs.

[34]  L. Trahms,et al.  LOCALIZATION AND QUANTIFICATION OF MAGNETIC NANOPARTICLES BY MULTICHANNEL MAGNETORELAXOMETRY FOR THERMAL ABLATION STUDIES , 2010 .

[35]  Austin D. Swafford,et al.  Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes , 2008, Proceedings of the National Academy of Sciences.

[36]  Jan Grimm,et al.  Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging. , 2009, Small.

[37]  Ji-Xin Cheng,et al.  Hyperthermic effects of gold nanorods on tumor cells. , 2007, Nanomedicine.

[38]  Paras N Prasad,et al.  Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy. , 2006, Molecular pharmaceutics.

[39]  Thomas Kelly,et al.  In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. , 2009, Nature nanotechnology.

[40]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[41]  Mark E. Davis,et al.  First-in-human phase I trial of a cyclodextrin-containing polymer-camptothecin nanoparticle in patients with solid tumors , 2007 .

[42]  K K Jain,et al.  Recent Advances in Nanooncology , 2008, Technology in cancer research & treatment.